H
Harvest
Tax-loss replacement research
VRTX
Vertex Pharmaceuticals
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for VRTX

Among the 28 Biotechnology peers screened, AMGN (Amgen Inc.) has tracked VRTX most closely over the past year, with a return correlation of 0.49. The strongest fund stand-in is IBB (iShares Biotechnology ETF) at 0.66 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
AMGNAmgen Inc.Biotechnology0.490.380.380.44
BIIBBiogen Inc.Biotechnology0.460.340.350.32
GILDGilead SciencesBiotechnology0.440.330.370.40
BMRNBioMarin PharmaceuticalBiotechnology0.400.260.320.41
INCYIncyteBiotechnology0.380.320.360.43
REGNRegeneron PharmaceuticalsBiotechnology0.370.350.380.46
HALOHalozymeBiotechnology0.350.210.240.31
VIRVir Biotechnology, Inc.Biotechnology0.320.240.230.12
EXELExelixisBiotechnology0.310.200.230.33
KRYSKrystal BiotechBiotechnology0.290.260.220.22
SRPTSarepta TherapeuticsBiotechnology0.290.230.240.24
MRNAModerna Inc.Biotechnology0.280.210.200.18
NBIXNeurocrine BiosciencesBiotechnology0.270.210.260.35
CYTKCytokineticsBiotechnology0.270.170.190.23
ALNYAlnylam PharmaceuticalsBiotechnology0.260.200.210.29
XNCRXencor IncBiotechnology0.250.250.270.31
ROIVRoivant SciencesBiotechnology0.240.220.22
VCELVericelBiotechnology0.230.220.220.22
RCUSArcus Biosciences, Inc.Biotechnology0.220.220.220.24
ARWRArrowhead PharmaceuticalsBiotechnology0.220.250.280.26
UTHRUnited TherapeuticsBiotechnology0.210.190.250.30
TGTXTG Therapeutics, Inc.Biotechnology0.210.190.210.24
RGENRepligenBiotechnology0.200.210.220.30
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.200.200.210.30
FTREFortreaBiotechnology0.190.180.18
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.190.130.18
ADMAADMA Biologics, Inc.Biotechnology0.190.200.220.15
PTGXProtagonist Therapeutics, Inc.Biotechnology0.160.190.140.13
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.660.560.550.62
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.620.500.520.57
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.610.500.520.57
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.610.500.520.57
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.600.490.520.56
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.540.440.470.51
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.530.440.470.52
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.490.420.410.50
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.390.360.400.46
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.360.300.320.40
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.320.270.340.44
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.230.220.310.38
NEXT STEPS

Harvesting a loss in VRTX?

RELATED

Replacement research for VRTX's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.